Anatomical and Functional Results of Surgery of the Tympanic Membrane Perforation of the Child (PERFOPED)

December 20, 2017 updated by: Assistance Publique - Hôpitaux de Paris
This study is a retrospective cohort of patients minors during the operation of cartilage tympanoplasty for tympanic membrane perforation

Study Overview

Detailed Description

The investigators hypothesis is that the cartilage tympanoplastie lead to a closure of the tympanic membrane in 95% of cases. But the investigators believe that certain risk factors may influence the anatomical and functional results of tympanoplastie of the child and that their inclusion could improve these results.

For example, young age is not clear so far as a potential risk factor in the few studies analyzing this factor independently. A recommendation of the French Society of ENT surgery tympanic membrane perforation of the Child in 2006 recommended a minimum age of 6 years. However, the level of evidence of articles analyzed was small (it was basically a consensus of experts) and the investigators feel it necessary to study this factor by age (<7 years, 7-10 years, 11-14 years ,> 14 years) on a large cohort to determine the real influence of age on the anatomical and functional results as this may lead to changes in practice.

Similarly, whatever the influence of age in the general population, it could be a key criterion in children who have a particular field leading to prolonged tubal dysfunction (vélopalatines slots and craniofacial malformations), leading to raising the age of surgery tympanic closure: the investigators have for example in 1000 tympanoplasties for perforation, expected recruitment numbers in this study, 50 patients with craniofacial malformation or vélopalatine slot.

The purpose of this study is to investigate the factors influencing the anatomic outcome at one year of cartilage tympanoplastie child.

Study Type

Observational

Enrollment (Actual)

980

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75015
        • Hospital Necker - Enfants Malades

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 33 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Pediatric ENT Head and Neck Surgery, Necker hospital.

Description

Inclusion Criteria:

  • Patient minors during the operation of cartilage tympanoplasty for tympanic membrane perforation (tympanoplasty for this first ear)
  • Patient operated between early 1998 and late 2012
  • Postoperative audiometry and otoscopy available between 9 and 18 months after surgery

Exclusion Criteria:

  • History of tympanoplasty ipsilateral, tympanic membrane perforation associated with épidermose or cholesteatoma
  • The holders of the parent or the patient has reached majority informed the doctor of their refusal to data collection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Children aged under 7 years old when tympanoplatie
Collection of anatomical and functional results in the appearance of the tympanic membrane after surgery
Children aged 7 to 10 years at the tympanoplatie
Collection of anatomical and functional results in the appearance of the tympanic membrane after surgery
Children aged 11 to 14 years at the tympanoplatie
Collection of anatomical and functional results in the appearance of the tympanic membrane after surgery
Children aged over 14 years at the tympanoplatie
Collection of anatomical and functional results in the appearance of the tympanic membrane after surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
anatomical result of the appearance of the tympanoplasty (tympanic membrane perforation after surgery)
Time Frame: 12 months (range 9 to 18 months)
  • Closed eardrum
  • Abnormal eardrum perforation residual, ear effusion, progressive retraction cholesteatoma
12 months (range 9 to 18 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Factors influencing the functional outcome of the tympanoplasty
Time Frame: 12 months (range 9 to 18 months)
  • mean bone conduction (BC)
  • air conduction (AC)
  • residual air-bone gap (RR = AC-BC). AC, BC and RR means are calculated on an average of four frequencies 0.5, 1, 2, 4 kHz Good functional outcome will be determined by an average RR ≤20 dB. A labyrinthisation be defined by a mean post-op compounded BC over 10 dB or moypostop BC - BC moypréop> 10 dB.
12 months (range 9 to 18 months)
Factors influencing the functional outcome of the tympanoplasty
Time Frame: 36 months ( range 30 to 42 months)
  • mean bone conduction (BC)
  • air conduction (AC)
  • residual air-bone gap (RR = AC-BC). AC, BC and RR means are calculated on an average of four frequencies 0.5, 1, 2, 4 kHz Good functional outcome will be determined by an average RR ≤20 dB. A labyrinthisation be defined by a mean post-op compounded BC over 10 dB or moypostop BC - BC moypréop> 10 dB.
36 months ( range 30 to 42 months)
Change anatomical result of the tympanoplasty
Time Frame: 36 months ( range 30 to 42 months)
36 months ( range 30 to 42 months)
factors affecting the anatomical and functional results of the tympanoplasty.
Time Frame: 36 months ( range 30 to 42 months)
  • clinical examination by pediatric ENT
  • hearing test
36 months ( range 30 to 42 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Françoise DENOYELLE, MD, PhD, Hospital Necker - Enfants Malades

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 6, 2015

Primary Completion (Actual)

December 8, 2017

Study Completion (Actual)

December 8, 2017

Study Registration Dates

First Submitted

October 22, 2014

First Submitted That Met QC Criteria

November 18, 2014

First Posted (Estimate)

November 21, 2014

Study Record Updates

Last Update Posted (Actual)

December 21, 2017

Last Update Submitted That Met QC Criteria

December 20, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tympanic Membrane Perforation

Clinical Trials on Collection of anatomical and functional results in the appearance of the tympanic membrane after surgery

3
Subscribe